Amid a turbulent energy market, Northern Oil & Gas (NOG) has carved out a distinct niche. By eschewing traditional operations for a data-driven, non-operated model, the company is turning industry headwinds into a structural advantage, according to a detailed analysis from Asymmetric Capital.
Cloud provider CoreWeave faces investor lawsuits over capacity claims just as Nvidia doubles down with a major investment, placing the company at the center of a high-stakes debate on AI infrastructure's future.
Over 247,000 residential customers of Potomac Edison, a FirstEnergy subsidiary in Maryland, will see automatic credits on their utility bills this month. The move, part of a state-mandated relief program, underscores the delicate balance utilities must strike between regulatory compliance, infrastructure investment, and consumer affordability pressures.
Walt Disney Company reports 'headwinds' in foreign visitor numbers at its American resorts, mirroring a broader downturn in U.S. international tourism driven by geopolitical perceptions and shifting travel preferences.
Facing rising churn and fierce competition, Verizon's new leadership is pivoting from unpopular price hikes to a customer-centric strategy, leveraging AI and convergence to rebuild trust and retain subscribers.
Personal finance expert Dave Ramsey joins critics in dismissing the concept of a 50-year home loan, arguing it offers minimal monthly savings while drastically increasing long-term costs and risks for homeowners.
Chinese EV maker NIO Inc. is hitting new operational highs, reporting record quarterly deliveries and improving margins as its multi-brand strategy gains traction. With a strengthened balance sheet and a global expansion underway, analysts debate whether the company is nearing a crucial inflection point.
Amid a challenging market for biotech, C4 Therapeutics (NASDAQ: CCCC) is drawing investor attention with its targeted protein degradation platform. Backed by industry giants and focused on niche cancers, the clinical-stage company presents a high-risk, high-reward proposition. We examine the bull case and the road ahead.
ResMed Inc., the sleep therapy giant, faces a pivotal moment. While benefiting from a competitor's recall and a growing market funnel, emerging oral treatments and shifting dynamics pose fresh challenges to its long-held CPAP business model.
With voter registration closing Monday night, Texas gears up for a pivotal March primary. East Texas Democrats express cautious optimism about statewide prospects, while Republicans remain confident in their stronghold as key races take shape.
A North Carolina mother, mourning the loss of her daughter and the young woman's boyfriend in a head-on collision, speaks out against what she perceives as a culture of irresponsibility glorified in award shows and a justice system that failed to prevent a preventable tragedy.
AerCap Holdings N.V., the world's largest aircraft lessor, is drawing renewed attention from value investors. Despite geopolitical headwinds and a cyclical reputation, its robust cash flows, industry dominance, and compelling valuation present a strong case for a rerating, as global travel demand outpaces constrained aircraft supply.
An analysis of the bullish investment case for DaVita Inc. highlights its entrenched market position and cash flow discipline, while underscoring the significant regulatory and leverage risks inherent in the kidney care sector.
As Becton Dickinson's complex Reverse Morris Trust transaction nears its 2026 close, analysts argue the market is overlooking a significant value catalyst and an attractively priced remaining business.
State Rep. James Talarico pushes back against claims he called former Congressman Colin Allred a 'mediocre Black man,' attributing the dispute to a misinterpreted private conversation as a heated Democratic primary intensifies.
After years of struggle, Oatly Group AB (OTLY) is showing concrete signs of a sustainable turnaround, posting its first quarterly operating profit in ten years. Strategic moves, including debt restructuring and a key investor stake, are fueling optimism for the oatmilk pioneer's path to profitability.
A new national survey reveals a significant majority of American voters believe the rollout of artificial intelligence is happening too rapidly, coupled with profound doubts about federal regulators' capacity to oversee the technology effectively.
A massive release of Jeffrey Epstein investigation files by the Justice Department has left survivors reeling after personal information, including names and confidential statements, was left unredacted. Lawyers allege a "historic violation" of privacy, prompting urgent calls for judicial intervention.
Pfizer has secured global rights to Novavax's Matrix-M adjuvant technology, aiming to develop new vaccines for infectious diseases as it seeks to diversify its portfolio beyond pandemic-related sales.
Analysts are building a case for Atlassian's long-term growth, citing its accelerating cloud migration, rapid AI adoption, and central role in enterprise workflow orchestration as key drivers, even as revenue recognition shifts create near-term volatility.
